People with bowel cancer could eventually receive individually tailored treatment that is more effective with fewer side effects. Bowel cancer is the second most common form of cancer in Australia and it spreads in half of all cases, making treatment challenging. Associate Professor Vicki Whitehall from QIMR Berghofer  is using cancer cells from individual patients to test the effectiveness of different drugs.